Jingxin Feng1, Guiying Xu2, Jiwei Liu1, Na Zhang1, Lili Li3, Jiafei Ji4, Jianchao Zhang5, Lian Zhang6, Guannan Wang7, Xiuli Wang1, Jiang Tan1, Baiqu Huang4, Jun Lu4, Yu Zhang8. 1. The Institute of Genetics and Cytology, Northeast Normal University, No.5268 Renmin Street, Changchun, 130024, China. 2. The Breast Surgery, The Tumor Hospital of Jilin Province, Changchun, 130000, China. 3. Key Laboratory of Cancer Prevention and Therapy, Department of Bone and Soft Tissue Oncology, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, 300202, China. 4. The Key Laboratory of Molecular Epigenetics of Ministry of Education (MOE), Northeast Normal University, Changchun, 130024, China. 5. Shenzhen Key Laboratory for Molecular Biology of Neural Development, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, Guangdong, China. 6. Department of Pathology, The Second Hospital of Jilin University, Changchun, 130041, China. 7. National Engineering Laboratory for Druggable Gene and Protein Screening, Northeast Normal University, Changchun, 130117, China. 8. The Institute of Genetics and Cytology, Northeast Normal University, No.5268 Renmin Street, Changchun, 130024, China. zhangy288@nenu.edu.cn.
Abstract
PURPOSE: LSD1 is overexpressed in various cancers including breast cancer, but its functional roles in tumourigenesis are not fully understood. This study aims at revealing the role of LSD1 in breast cancer development. In addition, it has been reported that phosphorylation of the Serine 112 residue of LSD1 by PKCα is crucial for its function in gene regulation. We also explored whether this phosphorylation affects LSD1's role in breast cancer development. METHODS: This study includes LSD1 IHC data generated with tissue microarrays of 163 cases of breast cancer samples and 72 normal tissues. In vitro, role of LSD1, LSD1 S112D mutant (a phosphorylation simulation) and LSD1 S112A mutant (an unphosphorylation simulation) in induction of EMT is evaluated. Mechanismly, we checked the role of LSD1 and its mutant on E-cadherin promoter histone modifications. We also investigated the role of LSD1 and its mutants in metastasis with a nude mice model. RESULTS: We found LSD1 is expressed at a higher level in breast cancer tissues compared with that in normal tissues, and LSD1 expression is closely linked to breast cancer metastasis. LSD1 potentiates EMT in breast epithelia cells by repressing E-cadherin expression through demethylating H3K4me at gene's promoter, during which phosphorylation of LSD1 Ser112 is crucial for its binding and demethylation activity. In vivo, knockdown of LSD1 impairs the metastatic ability of MDA-MB-231 breast cancer cells in nude mice. Ectopic overexpression of either LSD1 or LSD1 S112D mutant (a phosphorylation simulation) facilitates metastasis, whereas the LSD1 S112A mutant (an unphosphorylation simulation) fails to affect the metastasis. CONCLUSIONS: Data presented in this report indicate that LSD1 is able to induce EMT and to promote metastasis in breast cancer, and phosphorylation at LSD1 Ser112 is crucial for these functions.
PURPOSE:LSD1 is overexpressed in various cancers including breast cancer, but its functional roles in tumourigenesis are not fully understood. This study aims at revealing the role of LSD1 in breast cancer development. In addition, it has been reported that phosphorylation of the Serine 112 residue of LSD1 by PKCα is crucial for its function in gene regulation. We also explored whether this phosphorylation affects LSD1's role in breast cancer development. METHODS: This study includes LSD1 IHC data generated with tissue microarrays of 163 cases of breast cancer samples and 72 normal tissues. In vitro, role of LSD1, LSD1S112D mutant (a phosphorylation simulation) and LSD1S112A mutant (an unphosphorylation simulation) in induction of EMT is evaluated. Mechanismly, we checked the role of LSD1 and its mutant on E-cadherin promoter histone modifications. We also investigated the role of LSD1 and its mutants in metastasis with a nude mice model. RESULTS: We found LSD1 is expressed at a higher level in breast cancer tissues compared with that in normal tissues, and LSD1 expression is closely linked to breast cancer metastasis. LSD1 potentiates EMT in breast epithelia cells by repressing E-cadherin expression through demethylating H3K4me at gene's promoter, during which phosphorylation of LSD1Ser112 is crucial for its binding and demethylation activity. In vivo, knockdown of LSD1 impairs the metastatic ability of MDA-MB-231 breast cancer cells in nude mice. Ectopic overexpression of either LSD1 or LSD1S112D mutant (a phosphorylation simulation) facilitates metastasis, whereas the LSD1S112A mutant (an unphosphorylation simulation) fails to affect the metastasis. CONCLUSIONS: Data presented in this report indicate that LSD1 is able to induce EMT and to promote metastasis in breast cancer, and phosphorylation at LSD1Ser112 is crucial for these functions.
Entities:
Keywords:
Breast cancer; EMT; LSD1; Metastasis; Phosphorylation
Authors: J Feng; L Li; N Zhang; J Liu; L Zhang; H Gao; G Wang; Y Li; Y Zhang; X Li; D Liu; J Lu; B Huang Journal: Oncogene Date: 2016-11-28 Impact factor: 9.867
Authors: Saqer F Alsaqer; Mustafa M Tashkandi; Vinay K Kartha; Ya-Ting Yang; Yazeed Alkheriji; Andrew Salama; Xaralabos Varelas; Maria Kukuruzinska; Stefano Monti; Manish V Bais Journal: Oncotarget Date: 2017-07-27
Authors: T Boulding; R D McCuaig; A Tan; K Hardy; F Wu; J Dunn; M Kalimutho; C R Sutton; J K Forwood; A G Bert; G J Goodall; L Malik; D Yip; J E Dahlstrom; A Zafar; K K Khanna; S Rao Journal: Sci Rep Date: 2018-01-08 Impact factor: 4.379
Authors: Amal Kamal Abdel-Aziz; Isabella Pallavicini; Elena Ceccacci; Giuseppe Meroni; Mona Kamal Saadeldin; Mario Varasi; Saverio Minucci Journal: Haematologica Date: 2019-09-19 Impact factor: 9.941